SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.370
+0.070 (5.38%)
Apr 23, 2025, 4:00 PM EDT - Market closed

SAB Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
1.322.2423.960.8855.24
Upgrade
Revenue Growth (YoY)
-40.94%-90.63%-60.73%10.21%1504.91%
Upgrade
Cost of Revenue
30.2516.5236.4457.1827.91
Upgrade
Gross Profit
-28.93-14.28-12.533.6927.33
Upgrade
Selling, General & Admin
13.9823.816.3817.096.77
Upgrade
Operating Expenses
13.9823.816.3817.096.77
Upgrade
Operating Income
-42.91-38.08-28.92-13.3920.56
Upgrade
Interest Expense
-0.32-0.32-0.3-0.29-0.47
Upgrade
Interest & Investment Income
1.290.580.070.020.03
Upgrade
Other Non Operating Income (Expenses)
7.81-4.3910.38-4.150
Upgrade
EBT Excluding Unusual Items
-34.13-42.19-18.76-17.8120.12
Upgrade
Gain (Loss) on Sale of Investments
0.03----
Upgrade
Gain (Loss) on Sale of Assets
--0.02--
Upgrade
Other Unusual Items
--0.030.67-
Upgrade
Pretax Income
-34.11-42.19-18.72-17.1420.12
Upgrade
Income Tax Expense
--0.03--
Upgrade
Net Income
-34.11-42.19-18.74-17.1420.12
Upgrade
Net Income to Common
-34.11-42.19-18.74-17.1420.12
Upgrade
Shares Outstanding (Basic)
96433
Upgrade
Shares Outstanding (Diluted)
96433
Upgrade
Shares Change (YoY)
67.74%26.86%59.20%1.21%-23.30%
Upgrade
EPS (Basic)
-3.68-7.64-4.31-6.277.92
Upgrade
EPS (Diluted)
-3.68-7.64-4.31-6.307.40
Upgrade
Free Cash Flow
-34.63-25.32-25.63-8.96-2.73
Upgrade
Free Cash Flow Per Share
-3.74-4.58-5.89-3.28-1.01
Upgrade
Gross Margin
---52.44%6.07%49.48%
Upgrade
Operating Margin
-3244.87%-1700.56%-120.97%-22.00%37.21%
Upgrade
Profit Margin
-2579.03%-1884.50%-78.40%-28.16%36.42%
Upgrade
Free Cash Flow Margin
-2618.65%-1130.71%-107.20%-14.71%-4.94%
Upgrade
EBITDA
-38.2-34.42-25.75-11.920.94
Upgrade
EBITDA Margin
---107.71%-19.55%37.91%
Upgrade
D&A For EBITDA
4.713.653.171.490.38
Upgrade
EBIT
-42.91-38.08-28.92-13.3920.56
Upgrade
EBIT Margin
---120.97%-22.00%37.21%
Upgrade
Revenue as Reported
1.322.2423.960.8855.24
Upgrade
Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q